Gareev Ilgiz, Jiang Jianhao, Beylerli Ozal, Beilerli Aferin, Ilyasova Tatiana, Shumadalova Alina, Bai Yunlong, Du Weijie, Yang Baofeng
Central Research Laboratory, Department of Pharmacology, Bashkir State Medical University, Republic of Bashkortostan, 3 Lenin Street, Ufa, 450008, Russia.
The State-Province Key Laboratories of Biomedicine Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education, Department of Pharmacology, College of Pharmacy, Harbin Medical University, Harbin, 150067, China.
Curr Med Chem. 2025;32(10):1934-1967. doi: 10.2174/0109298673284605240301035057.
The search for effective methods of treatment and prevention of oncological diseases, despite the successes achieved in recent decades, remains one of the most urgent issues in modern medicine. It is known that chemotherapy and radiation therapy are based on the induction of cell death by increasing the intracellular concentration of reactive oxygen species (ROS). To increase the effectiveness of chemo- and radiotherapy, inducing and increasing oxidative stress in tumor cells has been proposed. A new class of promising adjuvants in combination with anticancer therapy, which has already been shown to be effective in preclinical and clinical studies, includes natural and synthetic polyphenols. Polyphenolic compounds not only exhibit antitumor activity but also significantly reduce the resistance of tumor cells to chemo- and radiotherapy. However, almost all chemotherapeutic drugs and regimens of radiation treatment have a damaging toxic effect on normal tissues, which significantly affects the quality of life of patients, and treatment options for managing these side effects are limited. In this regard, some of the most promising agents for the management of toxic side effects are natural polyphenols. This study discusses the possible molecular mechanisms and prospects for the clinical use of natural and synthetic polyphenolic compounds in chemo- and radiotherapy. In addition, the protective role/effect of polyphenols on the effects of chemoand radiotherapy in tumor patients is discussed.
尽管近几十年来取得了一些成功,但寻找治疗和预防肿瘤疾病的有效方法仍然是现代医学中最紧迫的问题之一。众所周知,化疗和放疗是通过增加细胞内活性氧(ROS)浓度来诱导细胞死亡的。为了提高化疗和放疗的效果,人们提出在肿瘤细胞中诱导和增加氧化应激。一类新的、有前景的与抗癌治疗联合使用的佐剂,已在临床前和临床研究中显示出有效性,其中包括天然和合成多酚。多酚类化合物不仅具有抗肿瘤活性,还能显著降低肿瘤细胞对化疗和放疗的耐药性。然而,几乎所有的化疗药物和放疗方案都会对正常组织产生有害的毒性作用,这严重影响了患者的生活质量,而且处理这些副作用的治疗选择有限。在这方面,一些最有前景的管理毒性副作用的药物是天然多酚。本研究讨论了天然和合成多酚类化合物在化疗和放疗中可能的分子机制以及临床应用前景。此外,还讨论了多酚对肿瘤患者化疗和放疗效果的保护作用/效果。